Repeated introduction and spread of the MRSA clone t304/ST6 in northern Europe

M D Bartels1, P Worning1, L P Andersen2

  • 1Department of Clinical Microbiology, MRSA Knowledge Centre, Hvidovre Hospital, Denmark.

Abstract

Insights

The methicillin-resistant Staphylococcus aureus (MRSA) t304/ST6 clone has spread across Europe, originating from a common source. Its emergence in Europe may be linked to refugee influx from the Syrian Civil War.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) clones have emerged globally.
  • The t304/ST6 MRSA clone has become prevalent in many European countries.
  • Understanding the phylogeny and spread of emerging MRSA clones is crucial for public health.

Purpose of the Study:

  • To investigate the phylogeny and spread of the MRSA t304/ST6 clone in Europe.
  • To characterize clinical isolates of the t304/ST6 clone from multiple European countries.

Main Methods:

  • Whole genome sequencing (WGS) of 466 MRSA ST6 isolates from Denmark, France, Norway, Sweden, and the UK.
  • Characterization of spa-types, including t304 and related types.
  • Core genome multilocus sequence typing (cgMLST) using Ridom SeqSphere.

Main Results:

  • A minimum spanning tree (MST) revealed a large cluster of Danish isolates linked to a neonatal outbreak, distinct from other isolates.
  • Most isolates (95%) were Panton-Valentine leukocidin (PVL) negative and harbored SCCmec IVa.
  • A 19.769 bp plasmid carrying the blaZ gene was identified in one closed genome and found in 78% of isolates.

Conclusions:

  • The t304/ST6 clone is a successful emerging MRSA clone with a common origin, evidenced by interspersed isolates from multiple countries.
  • The clone's emergence in Europe coincides with the influx of refugees from the Syrian Civil War.
  • Further research is needed to fully understand the dynamics of MRSA clone dissemination.